Celina Whalley

Let’s Go Dotty for Lynch Syndrome – bridging the gap between testing and diagnosis

By Celina Whalley / March 22, 2024 / Comments Off on Let’s Go Dotty for Lynch Syndrome – bridging the gap between testing and diagnosis

Supporting Let’s Go Dotty: Lynch Syndrome Awareness Day March 22nd, 2024. A one-test NGS solution for Lynch Syndrome screening.

Read More

Screening for rare disease with next generation sequencing

By Celina Whalley / February 24, 2024 / Comments Off on Screening for rare disease with next generation sequencing

Screening for rare disease with a clinically enhanced exome panel enabling CNV, SNV and INDEL calling in coding and non-coding regions.

Read More

4 key factors influencing NGS custom panel design

By Celina Whalley / December 8, 2023 / Comments Off on 4 key factors influencing NGS custom panel design

Factors to take into account when planning custom panel design; target regions, coverage v depth, experimental noise and validation.

Read More

FFPE, cfDNA and gDNA: The guide to DNA sample types used in next generation sequencing

By Celina Whalley / December 7, 2023 / Comments Off on FFPE, cfDNA and gDNA: The guide to DNA sample types used in next generation sequencing

Review of DNA types used in next generation sequencing (NGS), their quality characteristics and influence on choice of NGS assay.

Read More

Tracking the evolution of SARS CoV-2 using whole genome sequencing (WGS)

By Celina Whalley / November 3, 2021 / Comments Off on Tracking the evolution of SARS CoV-2 using whole genome sequencing (WGS)

November 3, 2021. Reviewed by Victoria Simms, April 23, 2024. Why monitoring the evolution of the virus is crucial to public health Viral genome sequencing: the background story Rapid whole viral genome sequencing, decoding a pathogen’s entire genome, is essential to public health organizations and epidemiologists for tracking and surveillance of disease outbreaks. Genomic epidemiologists around the…

Read More